World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
116
Citations
55507
World Ranking
4320
National Ranking
2357

Robert L. Ferris publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Robert L. Ferris sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 694 publications — 80th percentile

80% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Robert L. Ferris D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Robert L. Ferris sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 116 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Robert L. Ferris is affiliated with the University of Pittsburgh in the United States. Their research is primarily situated within the field of medicine, with a focus on oncology, otorhinolaryngology, immunology, surgery, and pulmonary and respiratory medicine. The scientist's work spans over 477 publications, with a significant concentration in these specialized subfields.

Their research covers a variety of topics, extensively dealing with head and neck cancer studies, cancer immunotherapy and biomarkers, CAR-T cell therapy research, immunotherapy and immune responses, lung cancer treatments and mutations, cancer genomics and diagnostics, as well as colorectal and anal carcinomas.

Notable recent papers authored or co-authored by Robert L. Ferris include:

  • "Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer," 2020, Immunity
  • "Avelumab plus standard-of-care chemoradiotherapy versus chemoradiotherapy alone in patients with locally advanced squamous cell carcinoma of the head and neck: a randomised, double-blind, placebo-controlled, multicentre, phase 3 trial," 2021, The Lancet Oncology
  • "Durvalumab with or without tremelimumab in patients with recurrent or metastatic head and neck squamous cell carcinoma: EAGLE, a randomized, open-label phase III study," 2020, Annals of Oncology
  • "B cell signatures and tertiary lymphoid structures contribute to outcome in head and neck squamous cell carcinoma," 2021, Nature Communications
  • "Investigating immune and non-immune cell interactions in head and neck tumors by single-cell RNA sequencing," 2021, Nature Communications

Frequent co-authors collaborating with Robert L. Ferris include:

  • Dan P. Zandberg
  • Umamaheswar Duvvuri
  • Seungwon Kim
  • Heath D. Skinner
  • Lazar Vujanović

The scientist's work is commonly published in several key venues within oncology and immunotherapy research, such as:

  • Journal of Clinical Oncology
  • Clinical Cancer Research
  • Regular and Young Investigator Award Abstracts
  • Journal for ImmunoTherapy of Cancer
  • bioRxiv (Cold Spring Harbor Laboratory)

This substantial contribution to medical science, particularly in head and neck cancer and immunotherapy, reflects a broad and diverse research portfolio. The integration of clinical trials, translational studies, and single-cell analyses marks their work across multiple frontiers of oncology research.

Best Publications

  • Comprehensive genomic characterization of head and neck squamous cell carcinomas

    Michael S. Lawrence;Carrie Sougnez;Lee Lichtenstein;Kristian Cibulskis

  • Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck

    Robert L. Ferris;George Blumenschein;Jerome Fayette;Joel Guigay

  • Integrated Genomic Characterization of Papillary Thyroid Carcinoma

    Nishant Agrawal;Rehan Akbani;B. Arman Aksoy;Adrian Ally

  • Head and neck cancer

    Athanassios Argiris;Michalis V Karamouzis;David Raben;Robert L Ferris

  • Impact of Mutational Testing on the Diagnosis and Management of Patients with Cytologically Indeterminate Thyroid Nodules: A Prospective Analysis of 1056 FNA Samples

    Yuri E. Nikiforov;N. Paul Ohori;Steven P. Hodak;Sally E. Carty

  • Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor PD-L1 expression.

    Robert L. Ferris;George Blumenschein;Jerome Fayette;Joel Guigay

  • The Tumor Microenvironment Represses T Cell Mitochondrial Biogenesis to Drive Intratumoral T Cell Metabolic Insufficiency and Dysfunction

    Nicole E. Scharping;Ashley V. Menk;Rebecca S. Moreci;Ryan D. Whetstone

  • Lipid accumulation and dendritic cell dysfunction in cancer

    Donna L. Herber;Wei Cao;Yulia Nefedova;Sergey V. Novitskiy

  • Immunology and Immunotherapy of Head and Neck Cancer

    Robert L. Ferris

  • Immune Landscape of Viral- and Carcinogen-Driven Head and Neck Cancer

    Anthony R. Cillo;Cornelius H.L. Kürten;Cornelius H.L. Kürten;Tracy Tabib;Zengbiao Qi

  • Interferon-γ Drives Treg Fragility to Promote Anti-tumor Immunity

    Abigail E. Overacre-Delgoffe;Abigail E. Overacre-Delgoffe;Maria Chikina;Rebekah E. Dadey;Hiroshi Yano

  • Frequent mutation of the PI3K pathway in head and neck cancer defines predictive biomarkers

    Vivian W.Y. Lui;Matthew L. Hedberg;Hua Li;Bhavana S. Vangara

  • The changing therapeutic landscape of head and neck cancer.

    John D Cramer;Barbara Burtness;Quynh Thu Le;Robert L Ferris

  • The Society for Immunotherapy of Cancer consensus statement on immunotherapy for the treatment of squamous cell carcinoma of the head and neck (HNSCC)

    Ezra E.W. Cohen;R. Bryan Bell;Carlo B. Bifulco;Barbara Burtness

  • Highly accurate diagnosis of cancer in thyroid nodules with follicular neoplasm/suspicious for a follicular neoplasm cytology by ThyroSeq v2 next-generation sequencing assay.

    Yuri E. Nikiforov;Sally E. Carty;Simon I. Chiosea;Christopher Coyne

  • E1308: Phase II Trial of Induction Chemotherapy Followed by Reduced-Dose Radiation and Weekly Cetuximab in Patients With HPV-Associated Resectable Squamous Cell Carcinoma of the Oropharynx- ECOG-ACRIN Cancer Research Group.

    Shanthi Marur;Shuli Li;Anthony J. Cmelak;Maura L. Gillison

  • The Mutational Landscape of Adenoid Cystic Carcinoma

    Allen S Ho;Kasthuri Kannan;David M Roy;Luc G T Morris

  • Characterization of HPV and host genome interactions in primary head and neck cancers.

    Michael Parfenov;Chandra Sekhar Pedamallu;Nils Gehlenborg;Nils Gehlenborg;Samuel S. Freeman

  • Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial

    Kevin J Harrington;Robert L Ferris;George Blumenschein;A Dimitrios Colevas

  • Impact of the Multi-Gene ThyroSeq Next-Generation Sequencing Assay on Cancer Diagnosis in Thyroid Nodules with Atypia of Undetermined Significance/Follicular Lesion of Undetermined Significance Cytology

    Yuri E. Nikiforov;Sally E. Carty;Simon I. Chiosea;Christopher Coyne

Frequent Co-Authors

Jonas T. Johnson
Jonas T. Johnson University of Pittsburgh
William E. Gooding
William E. Gooding University of Pittsburgh
Jennifer R. Grandis
Jennifer R. Grandis University of California, San Francisco
Raja R. Seethala
Raja R. Seethala University of Pittsburgh
Robert I. Haddad
Robert I. Haddad Harvard University
Soldano Ferrone
Soldano Ferrone Harvard University
Kevin J. Harrington
Kevin J. Harrington Royal Marsden NHS Foundation Trust
Theresa L. Whiteside
Theresa L. Whiteside University of Pittsburgh
Lisa Licitra
Lisa Licitra University of Milan
Maura L. Gillison
Maura L. Gillison The University of Texas MD Anderson Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

If you’re considering a career in medicine, there are numerous online degree options that can support your goals or offer alternative pathways. Many students explore a healthcare administration degree online, which prepares graduates to manage healthcare facilities, improve operations, and ensure quality patient care without a direct clinical focus.

For those aiming for leadership roles, the cheapest online MHA programs offer a cost-effective way to gain advanced management skills in the healthcare sector. Alternatively, nurses looking to move into higher-level clinical practice may want to consider the most affordable online DNP programs, which can lead to roles in advanced practice, policy, or education.

If pharmacy is your area of interest, exploring Pharm D online programs can set you on a path to becoming a licensed pharmacist. These related online degrees offer flexible, affordable routes to a variety of rewarding healthcare careers beyond traditional medical school.

Best Scientists Citing Robert L. Ferris

Trending Scientists

Recently Published Articles